Case 2: Newly Diagnosed Ovarian Cancer, gBRCA-Mutated

Emerging Strategies in Breast Cancer Care Before, During and After SurgeryПодробнее

Case 2: Maintenance in BRCA1/2wt, HR-Proficient Ovarian CancerПодробнее

AACR 2011: Ovarian cancer patients with BRCA mutations show improved survival.Подробнее

Case 2: Olaparib in BRCA-Mutated Ovarian CancerПодробнее

Hereditary Ovarian Cancer – BRCA and BeyondПодробнее

Case 2: Treating BRCA-Mutated Ovarian CancerПодробнее

Detecting Somatic BRCA1/2 Mutations in Ovarian CancerПодробнее

Case 2: Primary Treatment OptionsПодробнее

SOLO-1: Olaparib or placebo for patients with newly diagnosed BRCA-mutated advanced ovarian cancerПодробнее

Ovarian Cancer: Testing for BRCA MutationsПодробнее

How do genetic testing results impact the treatment of my ovarian cancer?Подробнее

Hereditary Breast and Ovarian Cancers: Should I Seek Genetic Testing?Подробнее

Understanding BRCA 1/2 Cancer Risk | Dana-Farber Cancer InstituteПодробнее

Ovarian Cancer GeneticsПодробнее

Novel Therapies for Newly Diagnosed Advanced Ovarian CancerПодробнее

Optimizing BRCA Testing in Advanced Ovarian CancerПодробнее

Testing for BRCA and HRD in Ovarian CancerПодробнее

Experience Managing Newly Diagnosed Advanced Ovarian CancerПодробнее

Treatment Options for Patients with BRCA1/2Подробнее

How Common is Hereditary Breast & Ovarian Cancer?Подробнее